WebJun 29, 2024 · The TAPUR Study is the first clinical trial conducted by ASCO, the world’s leading professional organization representing physicians who care for people with cancer. This research study focuses on whether specific targeted therapies can benefit more patients outside of United States Food and Drug Administration -approved uses. WebFeb 8, 2024 · The TAPUR Study is a phase II basket trial that aims to evaluate activity of approved targeted agents in patients with advanced cancers with potentially actionable genomic variants. Data from a cohort of patients with metastatic castrate-resistant prostate cancer (mCRPC) and BRCA1 / 2 mutations treated with olaparib are reported. METHODS
Sign In TAPUR
WebOct 11, 2013 · Tapur 2.3 official released !! Today the source code of the Tapur is being released under the Apache 2.0 license with some exceptions. Tapur will stop working … WebFeb 26, 2016 · Note: TAPUR does not explicitly exclude any type of solid tumor, but the patient must have measurable and evaluable disease per RECIST v1.1. Exclusion … phillip boren
Map TAPUR
WebJun 6, 2024 · TAPUR allows any CLIA-certified, CAP-accredited lab to screen patients for TAPUR in order to make it as easy as possible for patients to gain access to testing. According to Schilsky, approximately 60 percent of the testing done in TAPUR is performed by Foundation Medicine, 20 percent is done by Caris Life Sciences, and the remaining … WebThe Targeted Agent and Profiling Utilization Registration (TAPUR) study Description The TAPUR study is a clinical trial that aims to improve our understanding of how … WebEligibility. 12 years of age or older (*Restrictions apply. Not all therapies are available for patients ; 18); Histologically-proven locally advanced or metastatic solid tumor, multiple … phillip boos